BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 16569519)

  • 1. Detection of human butyrylcholinesterase-nerve gas adducts by liquid chromatography-mass spectrometric analysis after in gel chymotryptic digestion.
    Tsuge K; Seto Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):21-30. PubMed ID: 16569519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantification of soman and VX adducts to butyrylcholinesterase, their aged methylphosphonic acid adduct and butyrylcholinesterase in plasma using an off-column procainamide-gel separation method combined with UHPLC-MS/MS.
    Liu CC; Huang GL; Xi HL; Liu SL; Liu JQ; Yu HL; Zhou SK; Liang LH; Yuan L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov; 1036-1037():57-65. PubMed ID: 27718463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve agent analogues that produce authentic soman, sarin, tabun, and cyclohexyl methylphosphonate-modified human butyrylcholinesterase.
    Gilley C; MacDonald M; Nachon F; Schopfer LM; Zhang J; Cashman JR; Lockridge O
    Chem Res Toxicol; 2009 Oct; 22(10):1680-8. PubMed ID: 19715348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomagnetic separation and quantification of butyrylcholinesterase nerve agent adducts in human serum.
    Sporty JL; Lemire SW; Jakubowski EM; Renner JA; Evans RA; Williams RF; Schmidt JG; van der Schans MJ; Noort D; Johnson RC
    Anal Chem; 2010 Aug; 82(15):6593-600. PubMed ID: 20617824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous Time-concentration Analysis of Soman and VX Adducts to Butyrylcholinesterase and Albumin by LC-MS-MS.
    Lee JY; Kim C; Lee YH
    J Anal Toxicol; 2018 Jun; 42(5):293-299. PubMed ID: 29618078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Online coupling of immunoextraction, digestion, and microliquid chromatography-tandem mass spectrometry for the analysis of sarin and soman-butyrylcholinesterase adducts in human plasma.
    Bonichon M; Valbi V; Combès A; Desoubries C; Bossée A; Pichon V
    Anal Bioanal Chem; 2018 Jan; 410(3):1039-1051. PubMed ID: 28971225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) for detection and identification of albumin phosphylation by organophosphorus pesticides and G- and V-type nerve agents.
    John H; Breyer F; Thumfart JO; Höchstetter H; Thiermann H
    Anal Bioanal Chem; 2010 Nov; 398(6):2677-91. PubMed ID: 20730528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry.
    Li H; Schopfer LM; Nachon F; Froment MT; Masson P; Lockridge O
    Toxicol Sci; 2007 Nov; 100(1):136-45. PubMed ID: 17698511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of sarin(Se) reactivity against human plasma proteins using liquid chromatography-tandem mass spectrometry.
    Saeidian H; Hosseini SE; Amoozadeh A; Naseri MT; Babri M
    J Mass Spectrom; 2018 Feb; 53(2):138-145. PubMed ID: 29134720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-scale purification of butyrylcholinesterase from human plasma and implementation of a μLC-UV/ESI MS/MS method to detect its organophosphorus adducts.
    John H; Breyer F; Schmidt C; Mizaikoff B; Worek F; Thiermann H
    Drug Test Anal; 2015 Oct; 7(10):947-56. PubMed ID: 25828536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast affinity purification coupled with mass spectrometry for identifying organophosphate labeled plasma butyrylcholinesterase.
    Li H; Tong L; Schopfer LM; Masson P; Lockridge O
    Chem Biol Interact; 2008 Sep; 175(1-3):68-72. PubMed ID: 18586231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of pyrophosphate-like adducts from nerve agents sarin, soman and cyclosarin in phosphate buffer: implications for analytical and toxicological investigations.
    Gäb J; John H; Blum MM
    Toxicol Lett; 2011 Jan; 200(1-2):34-40. PubMed ID: 20979985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of nerve agent adducts with albumin in rat plasma using liquid chromatography-isotope dilution tandem mass spectrometry.
    Bao Y; Liu Q; Chen J; Lin Y; Wu B; Xie J
    J Chromatogr A; 2012 Mar; 1229():164-71. PubMed ID: 22305360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable adducts of nerve agents sarin, soman and cyclosarin with TRIS, TES and related buffer compounds--characterization by LC-ESI-MS/MS and NMR and implications for analytical chemistry.
    Gäb J; John H; Melzer M; Blum MM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(17-18):1382-90. PubMed ID: 20172768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of organophosphorus compound adducts of serine proteases by liquid chromatography-tandem mass spectrometry.
    Tsuge K; Seto Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Aug; 776(1):79-88. PubMed ID: 12127328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel dual-mode immunomagnetic method for studying reactivation of nerve agent-inhibited butyrylcholinesterase.
    Abney CW; Knaack JL; Ali AA; Johnson RC
    Chem Res Toxicol; 2013 May; 26(5):775-82. PubMed ID: 23656164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous measurement of tabun, sarin, soman, cyclosarin, VR, VX, and VM adducts to tyrosine in blood products by isotope dilution UHPLC-MS/MS.
    Crow BS; Pantazides BG; Quiñones-González J; Garton JW; Carter MD; Perez JW; Watson CM; Tomcik DJ; Crenshaw MD; Brewer BN; Riches JR; Stubbs SJ; Read RW; Evans RA; Thomas JD; Blake TA; Johnson RC
    Anal Chem; 2014 Oct; 86(20):10397-405. PubMed ID: 25286390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. V-type nerve agents phosphonylate ubiquitin at biologically relevant lysine residues and induce intramolecular cyclization by an isopeptide bond.
    Schmidt C; Breyer F; Blum MM; Thiermann H; Worek F; John H
    Anal Bioanal Chem; 2014 Aug; 406(21):5171-85. PubMed ID: 24652148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verification of exposure to cholinesterase inhibitors: generic detection of OPCW Schedule 1 nerve agent adducts to human butyrylcholinesterase.
    van der Schans MJ; Fidder A; van Oeveren D; Hulst AG; Noort D
    J Anal Toxicol; 2008; 32(1):125-30. PubMed ID: 18269804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioanalytical verification of V-type nerve agent exposure: simultaneous detection of phosphonylated tyrosines and cysteine-containing disulfide-adducts derived from human albumin.
    Kranawetvogl A; Küppers J; Siegert M; Gütschow M; Worek F; Thiermann H; Elsinghorst PW; John H
    Anal Bioanal Chem; 2018 Feb; 410(5):1463-1474. PubMed ID: 29322229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.